Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Verougstraete

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Therapeutic Drug Monitoring|March 10, 2026
Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin MeasurementCathérine Van Herteryck, Tim Reyns, Nynke Jager, et al.
Clinical Biochemistry|September 30, 2024
Analytical evaluation of a direct ion-selective-based analyser: Still gaps to closeMatthijs Oyaert, Nick Verougstraete, Brecht Vandekerckhove, et al.
Journal of Analytical Toxicology|December 28, 2018
Lethal Injection of a Castor Bean Extract: Ricinine Quantification as a Marker for Ricin Exposure Using a Validated LC-MS/MS MethodNick Verougstraete, Dries Helsloot, Christa Deprez, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2016
Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patientsNick Verougstraete, Bruno Lapauw, Sara Van Aken, et al.
Sexually Transmitted Infections|May 15, 2020
To pool or not to pool? Screening of <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> in female sex workers: pooled versus single-site testingNick Verougstraete, Vanessa Verbeke, Anne-Sophie De Cannière, et al.
Acta Clinica Belgica|July 26, 2024
Retrospective analysis of a flucloxacillin oral absorption test in patients requiring flucloxacillin therapy: results and determination of factors associated with adequate absorptionSanne De Smet, Pieter De Cock, Nick Verougstraete, et al.
British Journal of Clinical Pharmacology|May 21, 2020
Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncologyBradley D Menz, Sophie L Stocker, Nick Verougstraete, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 8, 2025
Synthetic cathinones in Belgium: a cluster of poly-drug intoxications involving α-pyrrolidinoisohexiophenone (α-PiHP)Margot Balcaen, Nik De Brabanter, Nick Verougstraete, et al.
Journal of Analytical Toxicology|August 4, 2020
First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?Nick Verougstraete, Marthe M Vandeputte, Cathelijne Lyphout, et al.
Cornea|January 31, 2024
Levamisole-Adulterated Cocaine-Induced Mucous Membrane Pemphigoid: Case Reports and Literature ReviewElke Thijs, Daire Hurley, Brendan Cummings, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Therapeutic Drug Monitoring|March 10, 2026
Addressing Analytical Challenges to Improve Laboratory Consistency in Unbound Flucloxacillin MeasurementCathérine Van Herteryck, Tim Reyns, Nynke Jager, et al.
Clinical Biochemistry|September 30, 2024
Analytical evaluation of a direct ion-selective-based analyser: Still gaps to closeMatthijs Oyaert, Nick Verougstraete, Brecht Vandekerckhove, et al.
Journal of Analytical Toxicology|December 28, 2018
Lethal Injection of a Castor Bean Extract: Ricinine Quantification as a Marker for Ricin Exposure Using a Validated LC-MS/MS MethodNick Verougstraete, Dries Helsloot, Christa Deprez, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2016
Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patientsNick Verougstraete, Bruno Lapauw, Sara Van Aken, et al.
Sexually Transmitted Infections|May 15, 2020
To pool or not to pool? Screening of <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> in female sex workers: pooled versus single-site testingNick Verougstraete, Vanessa Verbeke, Anne-Sophie De Cannière, et al.
Acta Clinica Belgica|July 26, 2024
Retrospective analysis of a flucloxacillin oral absorption test in patients requiring flucloxacillin therapy: results and determination of factors associated with adequate absorptionSanne De Smet, Pieter De Cock, Nick Verougstraete, et al.
British Journal of Clinical Pharmacology|May 21, 2020
Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncologyBradley D Menz, Sophie L Stocker, Nick Verougstraete, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 8, 2025
Synthetic cathinones in Belgium: a cluster of poly-drug intoxications involving α-pyrrolidinoisohexiophenone (α-PiHP)Margot Balcaen, Nik De Brabanter, Nick Verougstraete, et al.
Journal of Analytical Toxicology|August 4, 2020
First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?Nick Verougstraete, Marthe M Vandeputte, Cathelijne Lyphout, et al.
Cornea|January 31, 2024
Levamisole-Adulterated Cocaine-Induced Mucous Membrane Pemphigoid: Case Reports and Literature ReviewElke Thijs, Daire Hurley, Brendan Cummings, et al.
Pageof 3